Read the docs
TI-2006-05186 Aliases CVE-2006-5374GHSA-x8jc-rp2j-5v75

Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact…

Priority MEDIUM 50Published · Updated

Key facts

Attack vector
Network
Privileges required
None
User interaction
— Not recorded in CVSS 2.0
Attack complexity
Low
Impact type
—
Confidentiality · integrity · availability
Complete · Complete · Complete
Fix status
No fix listed

Attack profile from CVSS 2.0 · NVD. Fix status from CNA.

Summary

Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.

Why it matters now

EPSS 0.0416 90th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

Not available: CISA has not published SSVC decision points for this record.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:oracle:pharmaceutical:4.5.1:*:*:*:*:*:*:*4.5.1VulnerableOracle
  • cpe:2.3:a:oracle:pharmaceutical:4.5.1:*:*:*:*:*:*:* Versions 4.5.1 Vulnerable ·Oracle

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2006-5374
  2. 2026-10-03 Alias added: GHSA-x8jc-rp2j-5v75

References

Advisory 1

Other 3

  • TI-2006-01829 Unspecified vulnerability in the Oracle Thesaurus Management System component in Oracle… CVSS 2.0HIGH 10.0

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences